Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies

Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies

US Patent 9636415 · Granted May 2, 2017

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multivalent immunoglobulins2023
Synthetic immunoglobulin domains with binding properties engineered in regions o2022
Her2/neu immunogenic composition2021
Coiled-coil connector2021
Synthetic immunoglobulin domains with binding properties engineered in regions o2021
Immunoregulatory vaccine2019
Synthetic immunoglobulin domains with binding properties engineered in regions o2019
Gastrin peptide immunogenic composition2019
Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for tr2019
Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for tr2019
Cytotoxic immunoglobulin2018
Cytotoxic immunoglobulin2018